XML 33 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
BASIS OF FINANCIAL STATEMENT PRESENTATION Restated Financial Statements (Tables)
 6 Months Ended 12 Months Ended
Jun. 30, 2017
Dec. 31, 2017
Income Statement [Abstract]    
Restatement to Prior Year Income [Table Text Block]
Adoption of the standards related to revenue recognition, pension accounting and cash receipts and payments impacted previously reported results as follows:
 
Condensed Consolidated Statement of Operations
 
For the Three Months Ended June 30, 2017
 
As Previously Reported
 
ASC 606 Revenue Adjustments
 
Pension Adjustments
 
As Adjusted
Total revenues
$
2,542.9

 
$
(14.7
)
 
$
—

 
$
2,528.2

Total cost of revenue
1,681.1

 
68.9

 
0.2

 
1,750.2

Gross profit
861.8

 
(83.6
)
 
(0.2
)
 
778.0

Selling, general and administrative expenses
435.3

 
(78.1
)
 
0.5

 
357.7

Other operating and non-operating expenses, net
141.4

 
0.4

 
(0.7
)
 
141.1

Provision for income taxes
96.2

 
(2.1
)
 
—

 
94.1

Net earnings
188.9

 
(3.8
)
 
—

 
185.1

Less: Net earnings attributable to noncontrolling interest
(0.3
)
 
—

 
—

 
(0.3
)
Net earnings attributable to Laboratory Corporation of America Holdings
$
188.6

 
$
(3.8
)
 
$
—

 
$
184.8

 
 
 
 
 
 
 
 
Basic earnings per share
$
1.84

 
 
 
 
 
$
1.80

Diluted earnings per share
$
1.82

 
 
 
 
 
$
1.78

 
Condensed Consolidated Statement of Operations
 
For the Six Months Ended June 30, 2017
 
As previously reported
 
ASC 606 Revenue Adjustments
 
Pension Adjustments
 
As Adjusted
Total revenues
$
4,989.9

 
$
(48.0
)
 
$
—

 
$
4,941.9

Total cost of revenue
3,324.5

 
126.7

 
0.2

 
3,451.4

Gross profit
1,665.4

 
(174.7
)
 
(0.2
)
 
1,490.5

Selling, general and administrative expenses
854.7

 
(154.9
)
 
0.8

 
700.6

Other operating and non-operating expenses, net
245.9

 
0.6

 
(1.0
)
 
245.5

Provision for income taxes
183.4

 
(7.4
)
 
—

 
176.0

Net earnings
381.4

 
(13.0
)
 
—

 
368.4

Less: Net earnings attributable to noncontrolling interest
(0.6
)
 
—

 
—

 
(0.6
)
Net earnings attributable to Laboratory Corporation of America Holdings
$
380.8

 
$
(13.0
)
 
$
—

 
$
367.8

 
 
 
 
 
 
 
 
Basic earnings per share
$
3.71

 

 

 
$
3.59

Diluted earnings per share
$
3.66

 

 

 
$
3.54

 
Condensed Consolidated Statement of Cash Flows
 
For the Six Months Ended June 30, 2017
 
As Previously Reported
 
Zero-Coupon Notes Adjustments
 
As Adjusted
Net cash provided by operating activities
$
544.4

 
$
(8.0
)
 
$
536.4

Net cash used for investing activities
(736.9
)
 
—

 
(736.9
)
Net cash provided by financing activities
46.9

 
8.0

 
54.9

Effect of exchange rate changes on cash and cash equivalents
11.8

 
—

 
11.8

Net decrease in cash and cash equivalents
$
(133.8
)
 
 
 
$
(133.8
)
  
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]  
 
Condensed Consolidated Balance Sheets
 
December 31, 2017
 
As Previously Reported
 
ASC 606 Revenue Adjustments
 
As Adjusted
Current assets
$
2,682.6

 
$
51.2

 
$
2,733.8

Long-term assets
13,885.4

 
53.8

 
13,939.2

Total assets
$
16,568.0

 
$
105.0

 
$
16,673.0

 
 
 
 
 
 
Current liabilities
$
2,046.1

 
$
139.6

 
$
2,185.7

Long-term liabilities
7,671.1

 
(8.7
)
 
7,662.4

Noncontrolling interest
20.8

 
—

 
20.8

Shareholders' equity
6,830.0

 
(25.9
)
 
6,804.1

Total liabilities and shareholders' equity
$
16,568.0

 
$
105.0

 
$
16,673.0